Literature DB >> 9542738

High spatial resolution and speed in MRSI.

S J Nelson1, D B Vigneron, J Star-Lack, J Kurhanewicz.   

Abstract

The in vivo applications of magnetic resonance spectroscopic imaging (MRSI) have expanded significantly over the past 10 years and have reached the point where clinical trials are underway for a number of different diseases. One of the limiting factors in the widespread use of this technology has been the lack of widely available tools for obtaining data which are localized to sufficiently small tissue volumes to make an impact upon diagnosis and treatment planning. This is especially difficult within the timeframe of a clinical MR examination, which requires that both anatomic and metabolic data are acquired and processed. Recent advances in the hardware and software associated with clinical scanners have provided the potential for improvements in the spatial and time resolution of imaging and spectral data. The two areas which hold the most promise in terms of MRSI data are the use of phased array coils and the implementation of echo planar k-space sampling techniques. These could have immediate impact for 1H MRSI and may prove valuable for future applications of 31P MRSI.

Entities:  

Mesh:

Year:  1997        PMID: 9542738     DOI: 10.1002/(sici)1099-1492(199712)10:8<411::aid-nbm496>3.0.co;2-8

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  11 in total

Review 1.  Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer.

Authors:  J Kurhanewicz; D B Vigneron; S J Nelson
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  On restoring motion-induced signal loss in single-voxel magnetic resonance spectra.

Authors:  Refaat E Gabr; Shashank Sathyanarayana; Michael Schär; Robert G Weiss; Paul A Bottomley
Journal:  Magn Reson Med       Date:  2006-10       Impact factor: 4.668

3.  Simultaneous in vivo positron emission tomography and magnetic resonance imaging.

Authors:  Ciprian Catana; Daniel Procissi; Yibao Wu; Martin S Judenhofer; Jinyi Qi; Bernd J Pichler; Russell E Jacobs; Simon R Cherry
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-04       Impact factor: 11.205

Review 4.  Metabolomic signature of brain cancer.

Authors:  Renu Pandey; Laura Caflisch; Alessia Lodi; Andrew J Brenner; Stefano Tiziani
Journal:  Mol Carcinog       Date:  2017-07-17       Impact factor: 4.784

5.  Peak-specific phase correction for automated spectrum processing of in vivo magnetic resonance spectroscopic imaging by using the multiscale approach.

Authors:  Xiaodong Zhang; Xiaoping Hu
Journal:  Bo Pu Xue Za Zhi       Date:  2014-03-05

6.  Imaging the extracellular pH of tumors by MRI after injection of a single cocktail of T1 and T2 contrast agents.

Authors:  Gary V Martinez; Xiaomeng Zhang; María L García-Martín; David L Morse; Mark Woods; A Dean Sherry; Robert J Gillies
Journal:  NMR Biomed       Date:  2011-05-23       Impact factor: 4.044

7.  Proton MRS imaging in pediatric brain tumors.

Authors:  Maria Zarifi; A Aria Tzika
Journal:  Pediatr Radiol       Date:  2016-05-27

8.  Applications of chemical shift imaging to marine sciences.

Authors:  Haakil Lee; Andrey Tikunov; Michael K Stoskopf; Jeffrey M Macdonald
Journal:  Mar Drugs       Date:  2010-08-19       Impact factor: 5.118

Review 9.  Advances in MR spectroscopy of the prostate.

Authors:  John Kurhanewicz; Daniel B Vigneron
Journal:  Magn Reson Imaging Clin N Am       Date:  2008-11       Impact factor: 2.266

10.  Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading.

Authors:  Mark J Albers; Robert Bok; Albert P Chen; Charles H Cunningham; Matt L Zierhut; Vickie Yi Zhang; Susan J Kohler; James Tropp; Ralph E Hurd; Yi-Fen Yen; Sarah J Nelson; Daniel B Vigneron; John Kurhanewicz
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.